XML 55 R45.htm IDEA: XBRL DOCUMENT v3.5.0.2
Net Loss Per Share (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Numerator        
Net loss attributable to Inovio Pharmaceuticals, Inc. $ (18,704,711) $ (6,248,250) $ (26,747,531) $ (16,830,029)
Reflect adjustment for decrease in fair value of warrant liability 0 (22,727) 0 (312,500)
Numerator for use in diluted loss per share $ (18,704,711) $ (6,270,977) $ (26,747,531) $ (17,142,529)
Denominator        
Weighted average number of common shares outstanding (shares) 72,957,159 67,655,975 72,591,986 64,198,528
Effect of dilutive potential common shares from warrants (shares) 0 182,763 0 177,995
Denominator for use in diluted loss per share (shares) 72,957,159 67,838,738 72,591,986 64,376,523
Net loss per share, diluted ($ per share) $ (0.26) $ (0.09) $ (0.37) $ (0.27)
Antidilutive securities excluded from computation of earnings per share, amount (shares) 7,736,360 6,853,635    
Options to purchase commons stock [Member]        
Denominator        
Antidilutive securities excluded from computation of earnings per share, amount (shares) 6,694,478 5,987,210    
Warrants to purchase common stock [Member]        
Denominator        
Antidilutive securities excluded from computation of earnings per share, amount (shares) 284,091 627,969    
Restricted stock units [Member]        
Denominator        
Antidilutive securities excluded from computation of earnings per share, amount (shares) 749,335 230,000    
Convertible preferred stock [Member]        
Denominator        
Antidilutive securities excluded from computation of earnings per share, amount (shares) 8,456 8,456